US4479795A
(en)
*
|
1979-06-29 |
1984-10-30 |
The Procter & Gamble Company |
Antimicrobial polymer compositions
|
US4764380A
(en)
*
|
1982-03-22 |
1988-08-16 |
Alza Corporation |
Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
|
US5366738A
(en)
*
|
1982-07-29 |
1994-11-22 |
Merck & Co., Inc. |
Controlled release drug dispersion delivery device
|
US4466705A
(en)
*
|
1982-09-30 |
1984-08-21 |
Michelson Paul E |
Fluid lens
|
US4709996A
(en)
*
|
1982-09-30 |
1987-12-01 |
Michelson Paul E |
Fluid lens
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
GB8305797D0
(en)
*
|
1983-03-02 |
1983-04-07 |
Graham N B |
Hydrogel-containing envelopes
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
AT394944B
(de)
*
|
1983-05-11 |
1992-07-27 |
Alza Corp |
Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung
|
NZ206600A
(en)
*
|
1983-05-11 |
1987-01-23 |
Alza Corp |
Osmotic drug delivery device
|
USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
AU591171B2
(en)
*
|
1983-11-02 |
1989-11-30 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4781714A
(en)
*
|
1983-11-02 |
1988-11-01 |
Alza Corporation |
Dispenser for delivering thermo-responsive composition
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4595583A
(en)
*
|
1984-03-19 |
1986-06-17 |
Alza Corporation |
Delivery system controlled administration of beneficial agent to ruminants
|
US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4927633A
(en)
*
|
1984-03-19 |
1990-05-22 |
Alza Corporation |
Dispenser for delivering drug to livestock
|
US4624945A
(en)
*
|
1984-03-19 |
1986-11-25 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4772474A
(en)
*
|
1985-08-09 |
1988-09-20 |
Alza Corporation |
Dispenser with internal arrangement of lamina means for dispensing beneficial agent
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4717566A
(en)
*
|
1984-03-19 |
1988-01-05 |
Alza Corporation |
Dosage system and method of using same
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
US4678467A
(en)
*
|
1984-03-21 |
1987-07-07 |
Alza Corporation |
Dispenser comprising capsule with volume displacing member
|
GB2155889B
(en)
*
|
1984-03-21 |
1988-03-02 |
Alza Corp |
Dispenser-capsule
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
US4627971A
(en)
*
|
1985-04-22 |
1986-12-09 |
Alza Corporation |
Osmotic device with self-sealing passageway
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4624847A
(en)
*
|
1985-04-22 |
1986-11-25 |
Alza Corporation |
Drug delivery device for programmed delivery of beneficial drug
|
US4717568A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Laminar arrangement for increasing delivery of beneficial agent from dispenser
|
US4717718A
(en)
*
|
1985-08-09 |
1988-01-05 |
Alza Corporation |
Device for the controlled delivery of a beneficial agent
|
US4883667A
(en)
*
|
1985-08-16 |
1989-11-28 |
Alza Corporation |
Process for forming dispensing device
|
US4643731A
(en)
*
|
1985-08-16 |
1987-02-17 |
Alza Corporation |
Means for providing instant agent from agent dispensing system
|
US5098425A
(en)
*
|
1985-08-16 |
1992-03-24 |
Alza Corporation |
Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
|
US4966767A
(en)
*
|
1985-08-16 |
1990-10-30 |
Alza Corporation |
Ruminant dispensing device comprising agent displacement member
|
US4704118A
(en)
*
|
1985-08-16 |
1987-11-03 |
Alza Corporation |
Ruminant dispensing device with thermo-activated memory
|
US4963141A
(en)
*
|
1985-08-16 |
1990-10-16 |
Alza Corporation |
Dispensing system for administering beneficial agent formulation to ruminants
|
US4871544A
(en)
*
|
1985-08-16 |
1989-10-03 |
Alza Corporation |
Ruminant dispensing device
|
US4865598A
(en)
*
|
1985-08-16 |
1989-09-12 |
Alza Corporation |
Dispensing system for administering beneficial agent
|
US4955881A
(en)
*
|
1985-08-16 |
1990-09-11 |
Alza Corporation |
Ruminant dispensing device
|
US4866040A
(en)
*
|
1986-01-06 |
1989-09-12 |
Alfred Stracher |
Aminocarnitine directed pharmaceutical agents
|
US5008288A
(en)
*
|
1986-01-06 |
1991-04-16 |
Alfred Stracher |
Carnitine directed pharmaceutical agents
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4723957A
(en)
*
|
1986-02-07 |
1988-02-09 |
Alza Corp. |
System for delivering drug with enhanced bioacceptability
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4865845A
(en)
*
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
GB2189702B
(en)
*
|
1986-04-30 |
1989-10-18 |
Alza Corp |
Dosage form with improved delivery capability
|
US4960416A
(en)
*
|
1986-04-30 |
1990-10-02 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4863456A
(en)
*
|
1986-04-30 |
1989-09-05 |
Alza Corporation |
Dosage form with improved delivery capability
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
US4983400A
(en)
*
|
1986-06-16 |
1991-01-08 |
Merck & Co., Inc. |
Controlled release combination of carbidopa/levodopa
|
US4755180A
(en)
*
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
CH668187A5
(de)
*
|
1986-08-07 |
1988-12-15 |
Ciba Geigy Ag |
Therapeutisches system mit systemischer wirkung.
|
USRE34990E
(en)
*
|
1986-08-07 |
1995-07-04 |
Ciba-Geigy Corporation |
Oral therapeutic system having systemic action
|
DE3868077D1
(de)
*
|
1987-01-14 |
1992-03-12 |
Ciba Geigy Ag |
Therapeutisches system fuer schwerloesliche wirkstoffe.
|
JPS63180224A
(ja)
*
|
1987-01-21 |
1988-07-25 |
Matsushita Electric Ind Co Ltd |
無線機のアンテナ回路
|
US4940465A
(en)
*
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
US4892778A
(en)
*
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5938654A
(en)
*
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US4876093A
(en)
*
|
1987-07-02 |
1989-10-24 |
Alza Corporation |
Dispenser with dispersing member for delivering beneficial agent
|
US4824675A
(en)
*
|
1987-07-13 |
1989-04-25 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4915949A
(en)
*
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
US4891223A
(en)
*
|
1987-09-03 |
1990-01-02 |
Air Products And Chemicals, Inc. |
Controlled release delivery coating formulation for bioactive substances
|
US4946687A
(en)
*
|
1987-10-02 |
1990-08-07 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4816263A
(en)
*
|
1987-10-02 |
1989-03-28 |
Alza Corporation |
Dosage form for treating cardiovascular diseases comprising isradipine
|
US4950486A
(en)
*
|
1987-10-02 |
1990-08-21 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US5019397A
(en)
*
|
1988-04-21 |
1991-05-28 |
Alza Corporation |
Aqueous emulsion for pharmaceutical dosage form
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
US5030456A
(en)
*
|
1988-11-07 |
1991-07-09 |
Alza Corporation |
Dosage form for treating cardiovascular diseases
|
US5376383A
(en)
*
|
1988-11-21 |
1994-12-27 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma-cholesterol levels
|
US4997658A
(en)
*
|
1988-11-21 |
1991-03-05 |
Merck & Co., Inc. |
Method for enhancing the lowering of plasma cholesterol levels
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5034229A
(en)
*
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
FI900470A0
(fi)
*
|
1989-01-31 |
1990-01-30 |
Int Pharma Agentur |
Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
|
DD295760A5
(de)
*
|
1989-01-31 |
1991-11-14 |
Martin-Luther-Universitaet Halle Wittenberg,De |
Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
|
US6200600B1
(en)
*
|
1989-02-16 |
2001-03-13 |
Btg International Limited |
Controlled delay release device
|
US5181505A
(en)
*
|
1989-03-08 |
1993-01-26 |
Lew Chel W |
Method and apparatus for delivery of a medicament in the oral cavity
|
US5002540A
(en)
*
|
1989-05-22 |
1991-03-26 |
Warren Kirschbaum |
Intravaginal device and method for delivering a medicament
|
US5776493A
(en)
*
|
1989-07-14 |
1998-07-07 |
Alza Corporation |
Oral osmotic device for delivery of nystatin with hydrogel driving member
|
US5021053A
(en)
*
|
1989-07-14 |
1991-06-04 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5030216A
(en)
*
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
US5660851A
(en)
*
|
1989-12-26 |
1997-08-26 |
Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem |
Ocular inserts
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5128145A
(en)
*
|
1990-06-13 |
1992-07-07 |
Alza Corporation |
Dosage form for Parkinson's disease, spasticity and muscle spasms
|
US5057321A
(en)
*
|
1990-06-13 |
1991-10-15 |
Alza Corporation |
Dosage form comprising drug and maltodextrin
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
NZ238867A
(en)
*
|
1990-07-12 |
1993-08-26 |
Alza Corp |
Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
|
US5147654A
(en)
*
|
1990-07-23 |
1992-09-15 |
Alza Corporation |
Oral osmotic device for delivering nicotine
|
EP0550641B1
(de)
*
|
1990-09-28 |
1994-05-25 |
Pfizer Inc. |
Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US5593852A
(en)
|
1993-12-02 |
1997-01-14 |
Heller; Adam |
Subcutaneous glucose electrode
|
US5861166A
(en)
*
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US5208037A
(en)
*
|
1991-04-22 |
1993-05-04 |
Alza Corporation |
Dosage forms comprising polymers comprising different molecular weights
|
US5198229A
(en)
*
|
1991-06-05 |
1993-03-30 |
Alza Corporation |
Self-retaining gastrointestinal delivery device
|
US5137727A
(en)
*
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5190765A
(en)
*
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
US5252338A
(en)
*
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
MX9205850A
(es)
*
|
1991-10-10 |
1993-06-01 |
Alza Corp |
Dispositivos de surtido osmotico de farmaco con materiales de pared hidrofobicos
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
US5543154A
(en)
*
|
1991-12-27 |
1996-08-06 |
Merck & Co., Inc. |
Controlled release nifedipine delivery device
|
US5223265A
(en)
*
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
US5248310A
(en)
*
|
1992-03-27 |
1993-09-28 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5512299A
(en)
*
|
1992-03-30 |
1996-04-30 |
Alza Corporation |
Method of treating oral inflammatory disease
|
US5869097A
(en)
*
|
1992-11-02 |
1999-02-09 |
Alza Corporation |
Method of therapy comprising an osmotic caplet
|
US5573776A
(en)
*
|
1992-12-02 |
1996-11-12 |
Alza Corporation |
Oral osmotic device with hydrogel driving member
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5498255A
(en)
*
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
HU213407B
(en)
*
|
1993-12-09 |
1997-06-30 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tablet with diffusive-osmotic release
|
US5474985A
(en)
*
|
1993-12-22 |
1995-12-12 |
The Regents Of The University Of California |
Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
|
GB9326267D0
(en)
*
|
1993-12-23 |
1994-02-23 |
Scherer Corp R P |
Expulsion of material
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5540665A
(en)
*
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5460826A
(en)
*
|
1994-06-27 |
1995-10-24 |
Alza Corporation |
Morphine therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5529787A
(en)
*
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US5633011A
(en)
*
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
IE70735B1
(en)
*
|
1994-08-15 |
1996-12-11 |
Elan Med Tech |
Orally administrable delivery device
|
US5837276A
(en)
*
|
1994-09-02 |
1998-11-17 |
Delab |
Apparatus for the delivery of elongate solid drug compositions
|
US5582591A
(en)
*
|
1994-09-02 |
1996-12-10 |
Delab |
Delivery of solid drug compositions
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US5614578A
(en)
*
|
1994-10-28 |
1997-03-25 |
Alza Corporation |
Injection-molded dosage form
|
US5582838A
(en)
*
|
1994-12-22 |
1996-12-10 |
Merck & Co., Inc. |
Controlled release drug suspension delivery device
|
US5534263A
(en)
*
|
1995-02-24 |
1996-07-09 |
Alza Corporation |
Active agent dosage form comprising a matrix and at least two insoluble bands
|
US5876741A
(en)
*
|
1995-03-30 |
1999-03-02 |
Medlogic Global Corporation |
Chemo-mechanical expansion delivery system
|
US5651979A
(en)
*
|
1995-03-30 |
1997-07-29 |
Gel Sciences, Inc. |
Apparatus and method for delivering a biologically active compound into a biological environment
|
SI9500173B
(sl)
*
|
1995-05-19 |
2002-02-28 |
Lek, |
Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US6262115B1
(en)
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
US6124355A
(en)
*
|
1995-05-22 |
2000-09-26 |
Guittard; George V. |
Oxybutynin therapy
|
US5817335A
(en)
*
|
1995-05-26 |
1998-10-06 |
Alza Corporation |
Osmotic device with high drug loading and delayed activation of drug delivery
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5800422A
(en)
*
|
1995-06-02 |
1998-09-01 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery and complete drug release
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5731001A
(en)
*
|
1995-06-07 |
1998-03-24 |
Magruder; Judy A. |
Locking couplings for osmotic delivery devices
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
US5780058A
(en)
*
|
1995-07-21 |
1998-07-14 |
Alza Corporation |
Oral delivery of discrete units
|
US5840332A
(en)
*
|
1996-01-18 |
1998-11-24 |
Perio Products Ltd. |
Gastrointestinal drug delivery system
|
DK0914097T3
(da)
*
|
1996-03-12 |
2002-04-29 |
Alza Corp |
Sammensætning og doseringsform omfattende opioid antagonist
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
ZA97976B
(en)
*
|
1996-04-05 |
1997-08-18 |
Alza Corp |
Uniform drug delivery theraphy.
|
US5902605A
(en)
*
|
1996-04-18 |
1999-05-11 |
Alza Corporation |
Drug delivery device with minimal residual drug retention
|
PT957899E
(pt)
*
|
1996-08-16 |
2003-07-31 |
Alza Corp |
Forma de dosagem para proporcionar um medicamento numa dose crescente
|
DK0936894T3
(da)
*
|
1996-10-18 |
2001-11-19 |
Alza Corp |
Indretning til afgivelse af aktivt middel
|
JP3287576B2
(ja)
*
|
1996-10-18 |
2002-06-04 |
アルザ コーポレイション |
別々の単一体の経口投与用複数流路装置
|
US6024721A
(en)
*
|
1996-10-18 |
2000-02-15 |
Alza Corporation |
Mixing system for an active agent delivery device
|
WO1998018452A1
(en)
*
|
1996-10-25 |
1998-05-07 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
EP1782798A3
(de)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Darreichungsform mit ansteigender Dosisfreisetzung
|
DE69735848T2
(de)
*
|
1996-11-25 |
2006-12-28 |
Alza Corp., Palo Alto |
Dosisform mit ansteigender dosisfreisetzung
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
US5922352A
(en)
*
|
1997-01-31 |
1999-07-13 |
Andrx Pharmaceuticals, Inc. |
Once daily calcium channel blocker tablet having a delayed release core
|
US5837379A
(en)
*
|
1997-01-31 |
1998-11-17 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
US20030100532A1
(en)
*
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
US5948787A
(en)
*
|
1997-02-28 |
1999-09-07 |
Alza Corporation |
Compositions containing opiate analgesics
|
WO1998051259A1
(en)
*
|
1997-05-16 |
1998-11-19 |
Alza Corporation |
Flow controller configurations for an active agent delivery device
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
ATE282407T1
(de)
|
1997-09-09 |
2004-12-15 |
Alza Corp |
Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
US7060734B1
(en)
|
1997-09-09 |
2006-06-13 |
Alza Corporation |
Pharmaceutical coating composition and method of use
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
DE69821520T2
(de)
|
1997-11-10 |
2004-12-16 |
G.D. Searle & Co., Chicago |
Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz
|
EP1035834B1
(de)
|
1997-12-05 |
2002-04-17 |
Alza Corporation |
Osmotische darreichungsform mit zwei mantelschichten
|
US6485748B1
(en)
|
1997-12-12 |
2002-11-26 |
Andrx Pharmaceuticals, Inc. |
Once daily pharmaceutical tablet having a unitary core
|
CA2315890C
(en)
|
1997-12-22 |
2009-08-11 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
DE69932154T2
(de)
|
1998-02-12 |
2007-05-31 |
G.D. Searle Llc, Chicago |
Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
|
US6134461A
(en)
|
1998-03-04 |
2000-10-17 |
E. Heller & Company |
Electrochemical analyte
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
US6949816B2
(en)
|
2003-04-21 |
2005-09-27 |
Motorola, Inc. |
Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
|
US8465425B2
(en)
|
1998-04-30 |
2013-06-18 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6175752B1
(en)
|
1998-04-30 |
2001-01-16 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US8346337B2
(en)
|
1998-04-30 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8688188B2
(en)
|
1998-04-30 |
2014-04-01 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8480580B2
(en)
|
1998-04-30 |
2013-07-09 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US8974386B2
(en)
|
1998-04-30 |
2015-03-10 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US9066695B2
(en)
|
1998-04-30 |
2015-06-30 |
Abbott Diabetes Care Inc. |
Analyte monitoring device and methods of use
|
US6365183B1
(en)
|
1998-05-07 |
2002-04-02 |
Alza Corporation |
Method of fabricating a banded prolonged release active agent dosage form
|
KR100827254B1
(ko)
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US7890176B2
(en)
*
|
1998-07-06 |
2011-02-15 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating chronic pelvic pain
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
RU2224523C2
(ru)
|
1998-07-24 |
2004-02-27 |
Сео Хонг Ю |
Водный раствор, содержащий желчную кислоту, и способ его получения
|
EP1112060B1
(de)
*
|
1998-09-09 |
2005-12-07 |
ALZA Corporation |
Dosierungsform mit flüssiger formulierung
|
DE19842753A1
(de)
|
1998-09-18 |
2000-03-23 |
Bayer Ag |
Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US6087396A
(en)
*
|
1998-10-05 |
2000-07-11 |
Situs Corporation |
Oxybutynin formulations and method of use
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
ATE260642T1
(de)
*
|
1998-12-17 |
2004-03-15 |
Alza Corp |
Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
|
DK1140039T3
(da)
|
1998-12-18 |
2010-03-22 |
Alza Corp |
Transparente indretninger til perkutan nikotinadministration
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
JP2002534139A
(ja)
*
|
1999-01-05 |
2002-10-15 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
網膜と脈絡膜への経強膜徐放性薬剤標的送達
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
EP1027888B1
(de)
|
1999-02-10 |
2009-06-10 |
Pfizer Products Inc. |
Osmotisches System zur Verabreichung von Wirkstoffen, die feste amorphe Dispersionen enthalten
|
JP2002536407A
(ja)
|
1999-02-12 |
2002-10-29 |
ジー・ディー・サール・アンド・カンパニー |
肝炎ウィルス感染の治療のための置換−1,5−ジデオキシ−1,5−イミノ−d−グルシトール化合物の使用
|
US6515028B1
(en)
|
1999-02-12 |
2003-02-04 |
G.D. Searle & Co. |
Glucamine compounds for treating hepatitis virus infections
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
US8545880B2
(en)
*
|
1999-02-26 |
2013-10-01 |
Andrx Pharmaceuticals, Llc |
Controlled release oral dosage form
|
US6210716B1
(en)
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
WO2002043800A2
(en)
*
|
2000-11-29 |
2002-06-06 |
Durect Corporation |
Devices and methods for controlled delivery from a drug delivery device
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6217896B1
(en)
*
|
1999-04-01 |
2001-04-17 |
Uab Research Foundation |
Conjunctival inserts for topical delivery of medication or lubrication
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
US6287870B1
(en)
*
|
1999-08-20 |
2001-09-11 |
Robert A. Levine |
Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
CO5210862A1
(es)
|
1999-09-15 |
2002-10-30 |
Alza Corp |
Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
|
US6387325B1
(en)
*
|
1999-10-08 |
2002-05-14 |
Becton Dickinson & Company |
Assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
DE60016271T2
(de)
|
1999-10-21 |
2005-12-01 |
Alcon Inc. |
Medikamentenzuführvorrichtung
|
US6413245B1
(en)
|
1999-10-21 |
2002-07-02 |
Alcon Universal Ltd. |
Sub-tenon drug delivery
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
YU35302A
(sh)
*
|
1999-12-23 |
2005-03-15 |
Pfizer Products Inc. |
Dozirani oblik leka sa inicijalnim hidrogelom
|
WO2001047498A2
(en)
|
1999-12-23 |
2001-07-05 |
Pfizer Products Inc. |
Hydrogel-driven layered drug dosage form comprising sertraline
|
DE19962924A1
(de)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituierte Oxazolidinone und ihre Verwendung
|
US6669954B2
(en)
|
2000-01-25 |
2003-12-30 |
John R. Crison |
Controlled release of drugs
|
RU2277913C2
(ru)
*
|
2000-02-04 |
2006-06-20 |
Сео Хонг Ю |
Получение водного прозрачного раствора лекарственных форм с желчными кислотами
|
US20050119310A1
(en)
*
|
2000-02-14 |
2005-06-02 |
Mueller Richard A. |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6582441B1
(en)
|
2000-02-24 |
2003-06-24 |
Advanced Bionics Corporation |
Surgical insertion tool
|
US6855703B1
(en)
|
2000-03-10 |
2005-02-15 |
Endeavor Pharmaceuticals |
Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
|
US6660726B2
(en)
*
|
2000-03-10 |
2003-12-09 |
Endeavor Pharmaceuticals |
Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
|
US7989436B2
(en)
*
|
2003-07-23 |
2011-08-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and pharmaceutical formulations comprising the same
|
US7459445B2
(en)
*
|
2000-03-10 |
2008-12-02 |
Duramed Pharmaceuticals, Inc. |
Estrogenic compounds and topical pharmaceutical formulations of the same
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
WO2001080831A2
(en)
|
2000-04-27 |
2001-11-01 |
Verion Inc. |
Zero order release and temperature-controlled microcapsules and process for the preparation thereof
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
WO2003079972A2
(en)
|
2002-02-22 |
2003-10-02 |
New River Parmaceuticals Inc. |
Active agent delivery systems and methods for protecting and administering active agents
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
AU3649502A
(en)
|
2000-11-29 |
2002-06-11 |
Oculex Pharm Inc |
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
US6560471B1
(en)
|
2001-01-02 |
2003-05-06 |
Therasense, Inc. |
Analyte monitoring device and methods of use
|
US20060064140A1
(en)
*
|
2001-01-30 |
2006-03-23 |
Whitehurst Todd K |
Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
|
US20050143789A1
(en)
*
|
2001-01-30 |
2005-06-30 |
Whitehurst Todd K. |
Methods and systems for stimulating a peripheral nerve to treat chronic pain
|
US7493172B2
(en)
*
|
2001-01-30 |
2009-02-17 |
Boston Scientific Neuromodulation Corp. |
Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
|
IN190699B
(de)
|
2001-02-02 |
2003-08-16 |
Sun Pharmaceutical Ind Ltd |
|
NZ527930A
(en)
*
|
2001-03-16 |
2005-11-25 |
Andrx Pharmaceuticals Llc |
Controlled release sulfonylurea formulation
|
EP1397068A2
(de)
|
2001-04-02 |
2004-03-17 |
Therasense, Inc. |
Gerät und verfahren zur blutzuckerverfolgung
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US7563255B2
(en)
|
2001-05-03 |
2009-07-21 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
DE60239868D1
(de)
|
2001-06-12 |
2011-06-09 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
DE10129725A1
(de)
*
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US20040180087A1
(en)
*
|
2001-06-21 |
2004-09-16 |
Boyong Li |
Stable controlled release pharmaceutical compositions containing pravastatin
|
JP4249611B2
(ja)
*
|
2001-07-23 |
2009-04-02 |
アルコン,インコーポレイティド |
眼薬剤送致装置
|
WO2003009774A2
(en)
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US20030091634A1
(en)
*
|
2001-09-14 |
2003-05-15 |
Pawan Seth |
Delayed release tablet of venlafaxin
|
BR0212951A
(pt)
*
|
2001-09-28 |
2004-10-26 |
Mcneil Ppc Inc |
Formas de dosagens compósitas
|
US20030153864A1
(en)
*
|
2001-10-16 |
2003-08-14 |
Bernard Chaffringeon |
Disposable device and method for transferring an active liquid into a body cavity
|
US8329217B2
(en)
*
|
2001-11-06 |
2012-12-11 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dual controlled release dosage form
|
US20030185882A1
(en)
*
|
2001-11-06 |
2003-10-02 |
Vergez Juan A. |
Pharmaceutical compositions containing oxybutynin
|
US7183321B2
(en)
*
|
2001-12-17 |
2007-02-27 |
Bristol-Myers Squibb Company |
Antidiabetic formulation and method
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US9247901B2
(en)
|
2003-08-22 |
2016-02-02 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US10022078B2
(en)
|
2004-07-13 |
2018-07-17 |
Dexcom, Inc. |
Analyte sensor
|
US7613491B2
(en)
|
2002-05-22 |
2009-11-03 |
Dexcom, Inc. |
Silicone based membranes for use in implantable glucose sensors
|
US8010174B2
(en)
|
2003-08-22 |
2011-08-30 |
Dexcom, Inc. |
Systems and methods for replacing signal artifacts in a glucose sensor data stream
|
US8364229B2
(en)
|
2003-07-25 |
2013-01-29 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
US8260393B2
(en)
|
2003-07-25 |
2012-09-04 |
Dexcom, Inc. |
Systems and methods for replacing signal data artifacts in a glucose sensor data stream
|
US7514107B2
(en)
|
2002-03-21 |
2009-04-07 |
Mars, Incorporated |
Treatment of diseases involving defective gap junctional communication
|
WO2003086353A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Penwest Pharmaceuticals Co. |
Sustained release metoprolol formulations
|
US7125563B2
(en)
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US6733526B2
(en)
|
2002-04-25 |
2004-05-11 |
Advanced Medical Optics, Inc. |
Method of improving adherence and centering of intra-corneal implants on corneal bed
|
BR0309620A
(pt)
*
|
2002-04-29 |
2005-03-15 |
Alza Corp |
Métodos e formas de dosagem para liberação controlada de oxicodona
|
US20030224051A1
(en)
*
|
2002-05-31 |
2003-12-04 |
Fink Tracy A. |
Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
AU2003217531A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
US7328706B2
(en)
|
2002-05-06 |
2008-02-12 |
Dynamic Mouth Devices Llc |
Therapeutic and protective dental device useful as an intra-oral delivery system
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US7151961B1
(en)
*
|
2002-05-24 |
2006-12-19 |
Advanced Bionics Corporation |
Treatment of movement disorders by brain stimulation
|
US20040043067A1
(en)
*
|
2002-06-19 |
2004-03-04 |
Salamone Joseph C. |
Fluorosiloxane matrix controlled diffusion drug delivery systems
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20050175697A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Novel drug compositions and dosage forms of topiramate
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
NZ537543A
(en)
*
|
2002-07-29 |
2007-08-31 |
Alza Corp |
Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
|
US7254449B2
(en)
*
|
2002-07-31 |
2007-08-07 |
Advanced Bionics Corp |
Systems and methods for providing power to one or more implantable devices
|
EP1545551A4
(de)
|
2002-09-06 |
2008-10-22 |
Durect Corp |
Abgabe von modulatoren der glutamat-vermittelten neurotransmission an das innenohr
|
US20060009739A1
(en)
*
|
2002-09-06 |
2006-01-12 |
Durect Corporation |
Implantable flow regulator with failsafe mode and reserve drug supply
|
AU2003270778B2
(en)
*
|
2002-09-20 |
2009-10-08 |
Alpharma Pharmaceuticals, Llc |
Sequestering subunit and related compositions and methods
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
UY28056A1
(es)
*
|
2002-10-31 |
2003-12-31 |
Alza Corp |
Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
|
US7381184B2
(en)
|
2002-11-05 |
2008-06-03 |
Abbott Diabetes Care Inc. |
Sensor inserter assembly
|
GB2395126A
(en)
*
|
2002-11-09 |
2004-05-19 |
Reckitt Benckiser |
Volatile substance dispenser
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
JP4865330B2
(ja)
|
2002-12-13 |
2012-02-01 |
デュレクト コーポレーション |
経口ドラッグデリバリーシステム
|
AU2003303597A1
(en)
|
2002-12-31 |
2004-07-29 |
Therasense, Inc. |
Continuous glucose monitoring system and methods of use
|
DE10300111A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
WO2004064772A2
(en)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methods and dosage forms with modified viscosity layers
|
JP3811127B2
(ja)
*
|
2003-01-30 |
2006-08-16 |
株式会社東芝 |
情報記録装置及び情報記録方法
|
EP1592410B1
(de)
*
|
2003-02-11 |
2008-07-23 |
Alza Corporation |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
US6992075B2
(en)
*
|
2003-04-04 |
2006-01-31 |
Barr Laboratories, Inc. |
C(14) estrogenic compounds
|
WO2004091535A2
(en)
*
|
2003-04-11 |
2004-10-28 |
Barr Laboratories, Inc. |
Methods of administering estrogens and progestins
|
US20040213850A1
(en)
*
|
2003-04-25 |
2004-10-28 |
Eleni Dokou |
Sustained release delivery of a thrombin inhibitor
|
US20070083240A1
(en)
*
|
2003-05-08 |
2007-04-12 |
Peterson David K L |
Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
|
JP2007525188A
(ja)
|
2003-05-16 |
2007-09-06 |
インターミューン インコーポレイテッド |
合成ケモカイン受容体リガンドおよびその使用方法
|
US8066639B2
(en)
|
2003-06-10 |
2011-11-29 |
Abbott Diabetes Care Inc. |
Glucose measuring device for use in personal area network
|
US20040253293A1
(en)
*
|
2003-06-16 |
2004-12-16 |
Afshin Shafiee |
Rate controlled release of a pharmaceutical agent in a biodegradable device
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
JP2007526019A
(ja)
*
|
2003-07-10 |
2007-09-13 |
アルコン,インコーポレイティド |
眼科用薬物送達デバイス
|
US9763609B2
(en)
|
2003-07-25 |
2017-09-19 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
WO2007120442A2
(en)
|
2003-07-25 |
2007-10-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
US7774145B2
(en)
|
2003-08-01 |
2010-08-10 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8275437B2
(en)
|
2003-08-01 |
2012-09-25 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7591801B2
(en)
|
2004-02-26 |
2009-09-22 |
Dexcom, Inc. |
Integrated delivery device for continuous glucose sensor
|
US7494465B2
(en)
|
2004-07-13 |
2009-02-24 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US20190357827A1
(en)
|
2003-08-01 |
2019-11-28 |
Dexcom, Inc. |
Analyte sensor
|
WO2005016306A2
(en)
*
|
2003-08-06 |
2005-02-24 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
JP2007503389A
(ja)
*
|
2003-08-22 |
2007-02-22 |
アルザ・コーポレーシヨン |
長期間にわたるトピラメートの段階的送達
|
US7920906B2
(en)
|
2005-03-10 |
2011-04-05 |
Dexcom, Inc. |
System and methods for processing analyte sensor data for sensor calibration
|
US20140121989A1
(en)
|
2003-08-22 |
2014-05-01 |
Dexcom, Inc. |
Systems and methods for processing analyte sensor data
|
CA2564227A1
(en)
*
|
2003-09-02 |
2005-03-10 |
Alza Corporation |
Novel drug compositions and dosage forms of topiramate
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
WO2005030180A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Osmotic dosage forms for controlled delivery of alprazolam
|
WO2005030181A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
MXPA06003453A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
NZ546148A
(en)
|
2003-09-26 |
2009-05-31 |
Alza Corp |
Drug coating providing high drug loading and methods for providing the same
|
WO2005030182A1
(en)
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
US7407973B2
(en)
*
|
2003-10-24 |
2008-08-05 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
US20050118246A1
(en)
*
|
2003-10-31 |
2005-06-02 |
Wong Patrick S. |
Dosage forms and layered deposition processes for fabricating dosage forms
|
AU2004285532A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Administration of levodopa and carbidopa
|
US7299082B2
(en)
|
2003-10-31 |
2007-11-20 |
Abbott Diabetes Care, Inc. |
Method of calibrating an analyte-measurement device, and associated methods, devices and systems
|
USD914881S1
(en)
|
2003-11-05 |
2021-03-30 |
Abbott Diabetes Care Inc. |
Analyte sensor electronic mount
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US9247900B2
(en)
|
2004-07-13 |
2016-02-02 |
Dexcom, Inc. |
Analyte sensor
|
DE10355461A1
(de)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
|
JP5122821B2
(ja)
|
2003-11-28 |
2013-01-16 |
イーストマン ケミカル カンパニー |
セルロースインターポリマー及び酸化方法
|
US11633133B2
(en)
|
2003-12-05 |
2023-04-25 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
EP2239567B1
(de)
|
2003-12-05 |
2015-09-02 |
DexCom, Inc. |
Kalibrierverfahren für einen kontinuierlichen Analytsensor
|
US8423114B2
(en)
|
2006-10-04 |
2013-04-16 |
Dexcom, Inc. |
Dual electrode system for a continuous analyte sensor
|
WO2005062829A2
(en)
*
|
2003-12-19 |
2005-07-14 |
Advanced Bionics Corporation |
Skull-mounted electrical stimulation system and method for treating patients
|
JP2007516297A
(ja)
*
|
2003-12-23 |
2007-06-21 |
アルザ・コーポレーシヨン |
制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
|
CA2551815A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation |
Novel drug compositions and dosage forms
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
AU2005209201B2
(en)
|
2004-01-20 |
2010-06-03 |
Allergan, Inc. |
Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
|
EP1718198A4
(de)
|
2004-02-17 |
2008-06-04 |
Therasense Inc |
Verfahren und system zur bereitstellung einer datenkommunikation in einem kontinuierlichen blutzuckerüberwachungs- und managementsystem
|
US8808228B2
(en)
|
2004-02-26 |
2014-08-19 |
Dexcom, Inc. |
Integrated medicament delivery device for use with continuous analyte sensor
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050226929A1
(en)
*
|
2004-04-12 |
2005-10-13 |
Jianbo Xie |
Controlled release opioid analgesic formulation
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US8147865B2
(en)
*
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US8722097B2
(en)
*
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
BRPI0510485A
(pt)
|
2004-04-30 |
2007-11-13 |
Allergan Inc |
implantes inibidores de tirosina cinase intravìtreos biodegradáveis
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
DE102004023069A1
(de)
|
2004-05-11 |
2005-12-08 |
Bayer Healthcare Ag |
Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
|
US20050267555A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Marnfeldt Goran N |
Engagement tool for implantable medical devices
|
CA2572455C
(en)
|
2004-06-04 |
2014-10-28 |
Therasense, Inc. |
Diabetes care host-client architecture and data management system
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20080027513A1
(en)
*
|
2004-07-09 |
2008-01-31 |
Advanced Bionics Corporation |
Systems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical Device
|
JP2008505978A
(ja)
*
|
2004-07-12 |
2008-02-28 |
アラーガン、インコーポレイテッド |
眼病用組成物および眼病治療法
|
US7640048B2
(en)
|
2004-07-13 |
2009-12-29 |
Dexcom, Inc. |
Analyte sensor
|
US8565848B2
(en)
|
2004-07-13 |
2013-10-22 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8452368B2
(en)
|
2004-07-13 |
2013-05-28 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US7783333B2
(en)
|
2004-07-13 |
2010-08-24 |
Dexcom, Inc. |
Transcutaneous medical device with variable stiffness
|
US20060020192A1
(en)
|
2004-07-13 |
2006-01-26 |
Dexcom, Inc. |
Transcutaneous analyte sensor
|
US8452407B2
(en)
*
|
2004-08-16 |
2013-05-28 |
Boston Scientific Neuromodulation Corporation |
Methods for treating gastrointestinal disorders
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
ES2339790T3
(es)
*
|
2004-08-30 |
2010-05-25 |
Seo Hong Yoo |
Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
|
EP1802258A4
(de)
|
2004-09-13 |
2015-09-23 |
Chrono Therapeutics Inc |
Biosynchrone transdermale arzneiabgabe
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
BRPI0518191A
(pt)
*
|
2004-10-15 |
2008-11-04 |
Seo Hong Yoo |
métodos e composições para reduzir a toxicidade de um composto farmacêutico
|
AU2005302452B2
(en)
*
|
2004-11-01 |
2010-12-09 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in Amyotrophic Lateral Sclerosis
|
US9358393B1
(en)
|
2004-11-09 |
2016-06-07 |
Andres M. Lozano |
Stimulation methods and systems for treating an auditory dysfunction
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US7483746B2
(en)
*
|
2004-12-06 |
2009-01-27 |
Boston Scientific Neuromodulation Corp. |
Stimulation of the stomach in response to sensed parameters to treat obesity
|
US20070038264A1
(en)
*
|
2004-12-21 |
2007-02-15 |
Jaax Kristen N |
Methods and systems for treating autism
|
US9327069B2
(en)
|
2004-12-21 |
2016-05-03 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a medical condition by promoting neural remodeling within the brain
|
US9095713B2
(en)
*
|
2004-12-21 |
2015-08-04 |
Allison M. Foster |
Methods and systems for treating autism by decreasing neural activity within the brain
|
US20060161217A1
(en)
*
|
2004-12-21 |
2006-07-20 |
Jaax Kristen N |
Methods and systems for treating obesity
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
CN101437498A
(zh)
*
|
2004-12-22 |
2009-05-20 |
爱尔康公司 |
用于眼科给药的装置
|
US9352145B2
(en)
*
|
2004-12-22 |
2016-05-31 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating a psychotic disorder
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
US8515541B1
(en)
|
2004-12-22 |
2013-08-20 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating post-stroke disorders
|
US10226207B2
(en)
|
2004-12-29 |
2019-03-12 |
Abbott Diabetes Care Inc. |
Sensor inserter having introducer
|
US9788771B2
(en)
|
2006-10-23 |
2017-10-17 |
Abbott Diabetes Care Inc. |
Variable speed sensor insertion devices and methods of use
|
US9398882B2
(en)
|
2005-09-30 |
2016-07-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor and data processing device
|
US7697967B2
(en)
|
2005-12-28 |
2010-04-13 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
US9743862B2
(en)
|
2011-03-31 |
2017-08-29 |
Abbott Diabetes Care Inc. |
Systems and methods for transcutaneously implanting medical devices
|
US7731657B2
(en)
|
2005-08-30 |
2010-06-08 |
Abbott Diabetes Care Inc. |
Analyte sensor introducer and methods of use
|
US8613703B2
(en)
|
2007-05-31 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Insertion devices and methods
|
US9572534B2
(en)
|
2010-06-29 |
2017-02-21 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US20090105569A1
(en)
|
2006-04-28 |
2009-04-23 |
Abbott Diabetes Care, Inc. |
Introducer Assembly and Methods of Use
|
US8029441B2
(en)
|
2006-02-28 |
2011-10-04 |
Abbott Diabetes Care Inc. |
Analyte sensor transmitter unit configuration for a data monitoring and management system
|
US9636450B2
(en)
|
2007-02-19 |
2017-05-02 |
Udo Hoss |
Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
|
US9259175B2
(en)
|
2006-10-23 |
2016-02-16 |
Abbott Diabetes Care, Inc. |
Flexible patch for fluid delivery and monitoring body analytes
|
US8571624B2
(en)
|
2004-12-29 |
2013-10-29 |
Abbott Diabetes Care Inc. |
Method and apparatus for mounting a data transmission device in a communication system
|
US8333714B2
(en)
|
2006-09-10 |
2012-12-18 |
Abbott Diabetes Care Inc. |
Method and system for providing an integrated analyte sensor insertion device and data processing unit
|
US7883464B2
(en)
|
2005-09-30 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Integrated transmitter unit and sensor introducer mechanism and methods of use
|
US8512243B2
(en)
|
2005-09-30 |
2013-08-20 |
Abbott Diabetes Care Inc. |
Integrated introducer and transmitter assembly and methods of use
|
IL166114A0
(en)
*
|
2005-01-03 |
2006-01-15 |
Calcident Active Ltd |
Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
|
WO2006081569A2
(en)
*
|
2005-01-27 |
2006-08-03 |
Alza Corporation |
Oral osmotic dosage form having a high flux membrane
|
EP1685841A1
(de)
*
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prophylaxe und Behandlung von thrombolischen Erkrankungen
|
EP1853221A2
(de)
*
|
2005-02-03 |
2007-11-14 |
Duramed Pharmaceuticals, Inc. |
Vorrichtungen zur abgabe von mitteln in einen vaginaltrakt
|
EP1853272A1
(de)
*
|
2005-02-03 |
2007-11-14 |
Duramed Pharmaceuticals, Inc. |
Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
|
EP1690540A1
(de)
*
|
2005-02-15 |
2006-08-16 |
Neuro3D |
Zusammensetzung enthaltend Ocaperidon
|
US20060185665A1
(en)
*
|
2005-02-22 |
2006-08-24 |
Bachinski Thomas J |
Sauna fireplace
|
US20060194724A1
(en)
*
|
2005-02-25 |
2006-08-31 |
Whitehurst Todd K |
Methods and systems for nerve regeneration
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
US7848803B1
(en)
|
2005-03-14 |
2010-12-07 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US7853321B2
(en)
*
|
2005-03-14 |
2010-12-14 |
Boston Scientific Neuromodulation Corporation |
Stimulation of a stimulation site within the neck or head
|
US7702385B2
(en)
*
|
2005-11-16 |
2010-04-20 |
Boston Scientific Neuromodulation Corporation |
Electrode contact configurations for an implantable stimulator
|
US8423155B1
(en)
|
2005-03-14 |
2013-04-16 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for facilitating stimulation of one or more stimulation sites
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
JP2008536928A
(ja)
*
|
2005-04-19 |
2008-09-11 |
アルザ・コーポレーシヨン |
トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
|
US8112240B2
(en)
|
2005-04-29 |
2012-02-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing leak detection in data monitoring and management systems
|
US7931909B2
(en)
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
US20070003624A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Shanbhag Anant R |
Semi-permeable compositions providing reduced drying time for osmotic dosage forms
|
DE102005031577A1
(de)
*
|
2005-07-06 |
2007-01-11 |
Bayer Healthcare Ag |
Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
|
US9447781B2
(en)
*
|
2005-07-22 |
2016-09-20 |
University Of Utah Research Foundation |
Osmotically driven dispense pump and related components for use in high pressure applications
|
CA2616537A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
EP1912622A2
(de)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotische dosierungsformen mit halbdurchlässigen membranen mit polymer-mischungen mit verbesserten eigenschaften
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070048347A1
(en)
|
2005-08-26 |
2007-03-01 |
Laura Bardach |
Intra-oral device for treating obesity
|
CN102440785A
(zh)
|
2005-08-31 |
2012-05-09 |
弗吉尼亚大学专利基金委员会 |
传感器信号处理方法及传感器信号处理装置
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US7684858B2
(en)
*
|
2005-09-21 |
2010-03-23 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for placing an implanted stimulator for stimulating tissue
|
DE102005045518A1
(de)
*
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
|
US8182840B2
(en)
|
2005-09-27 |
2012-05-22 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US9521968B2
(en)
|
2005-09-30 |
2016-12-20 |
Abbott Diabetes Care Inc. |
Analyte sensor retention mechanism and methods of use
|
US8880138B2
(en)
|
2005-09-30 |
2014-11-04 |
Abbott Diabetes Care Inc. |
Device for channeling fluid and methods of use
|
DE102005047561A1
(de)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
|
KR101364400B1
(ko)
|
2005-10-04 |
2014-02-17 |
바이엘 인텔렉쳐 프로퍼티 게엠베하 |
5-클로로-n-({(5s)-2-옥소-3-[4-(3-옥소-4-모르폴리닐)-페닐]-1,3-옥사졸리딘-5-일}-메틸)-2-티오펜 카르복사미드의 신규 다형체 및 무정형 형태
|
DE102005047558A1
(de)
*
|
2005-10-04 |
2008-02-07 |
Bayer Healthcare Ag |
Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US7766829B2
(en)
|
2005-11-04 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and system for providing basal profile modification in analyte monitoring and management systems
|
EP1948246B1
(de)
*
|
2005-11-14 |
2017-05-03 |
Theragene Pharmaceuticals, Inc. |
Stammzellenfaktor-therapie für gewebeverletzungen
|
US7858609B2
(en)
|
2005-11-28 |
2010-12-28 |
Marinus Pharmaceuticals |
Solid ganaxolone formulations and methods for the making and use thereof
|
AU2006320535B2
(en)
|
2005-11-29 |
2010-09-23 |
Glaxosmithkline Llc |
Treatment method
|
US7729758B2
(en)
*
|
2005-11-30 |
2010-06-01 |
Boston Scientific Neuromodulation Corporation |
Magnetically coupled microstimulators
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
CA2636034A1
(en)
|
2005-12-28 |
2007-10-25 |
Abbott Diabetes Care Inc. |
Medical device insertion
|
US11298058B2
(en)
|
2005-12-28 |
2022-04-12 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor insertion
|
US7610100B2
(en)
*
|
2005-12-30 |
2009-10-27 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating osteoarthritis
|
US7835803B1
(en)
|
2006-01-17 |
2010-11-16 |
Boston Scientific Neuromodulation Corporation |
Lead assemblies with one or more switching networks
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US7736310B2
(en)
|
2006-01-30 |
2010-06-15 |
Abbott Diabetes Care Inc. |
On-body medical device securement
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
US7826879B2
(en)
|
2006-02-28 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Analyte sensors and methods of use
|
US7885698B2
(en)
|
2006-02-28 |
2011-02-08 |
Abbott Diabetes Care Inc. |
Method and system for providing continuous calibration of implantable analyte sensors
|
US8309104B2
(en)
*
|
2006-03-02 |
2012-11-13 |
Watson Pharmaceuticals, Inc. |
Oral controlled release formulation for sedative and hypnotic agents
|
EP1991110B1
(de)
*
|
2006-03-09 |
2018-11-07 |
DexCom, Inc. |
Systeme und verfahren zur aufbereitung von analytensensordaten
|
US8175710B2
(en)
*
|
2006-03-14 |
2012-05-08 |
Boston Scientific Neuromodulation Corporation |
Stimulator system with electrode array and the method of making the same
|
US7777641B2
(en)
*
|
2006-03-29 |
2010-08-17 |
Advanced Bionics, Llc |
Systems and methods of facilitating communication between a first and second device
|
US7630748B2
(en)
|
2006-10-25 |
2009-12-08 |
Abbott Diabetes Care Inc. |
Method and system for providing analyte monitoring
|
US8140312B2
(en)
|
2007-05-14 |
2012-03-20 |
Abbott Diabetes Care Inc. |
Method and system for determining analyte levels
|
US7653425B2
(en)
|
2006-08-09 |
2010-01-26 |
Abbott Diabetes Care Inc. |
Method and system for providing calibration of an analyte sensor in an analyte monitoring system
|
US8219173B2
(en)
|
2008-09-30 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Optimizing analyte sensor calibration
|
US7618369B2
(en)
|
2006-10-02 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for dynamically updating calibration parameters for an analyte sensor
|
US8226891B2
(en)
|
2006-03-31 |
2012-07-24 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods therefor
|
US9339217B2
(en)
|
2011-11-25 |
2016-05-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods of use
|
US8583205B2
(en)
|
2008-03-28 |
2013-11-12 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US8346335B2
(en)
|
2008-03-28 |
2013-01-01 |
Abbott Diabetes Care Inc. |
Analyte sensor calibration management
|
US9675290B2
(en)
|
2012-10-30 |
2017-06-13 |
Abbott Diabetes Care Inc. |
Sensitivity calibration of in vivo sensors used to measure analyte concentration
|
US8473022B2
(en)
|
2008-01-31 |
2013-06-25 |
Abbott Diabetes Care Inc. |
Analyte sensor with time lag compensation
|
US7620438B2
(en)
|
2006-03-31 |
2009-11-17 |
Abbott Diabetes Care Inc. |
Method and system for powering an electronic device
|
US8224415B2
(en)
|
2009-01-29 |
2012-07-17 |
Abbott Diabetes Care Inc. |
Method and device for providing offset model based calibration for analyte sensor
|
US8374668B1
(en)
|
2007-10-23 |
2013-02-12 |
Abbott Diabetes Care Inc. |
Analyte sensor with lag compensation
|
US7801582B2
(en)
|
2006-03-31 |
2010-09-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management system and methods therefor
|
US9392969B2
(en)
|
2008-08-31 |
2016-07-19 |
Abbott Diabetes Care Inc. |
Closed loop control and signal attenuation detection
|
US9561188B2
(en)
*
|
2006-04-03 |
2017-02-07 |
Intellipharmaceutics Corporation |
Controlled release delivery device comprising an organosol coat
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
US10960077B2
(en)
*
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
KR20090021169A
(ko)
*
|
2006-05-16 |
2009-02-27 |
크놉 뉴로사이언시스 인코포레이티드 |
R(+) 및 s(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
|
US7920907B2
(en)
|
2006-06-07 |
2011-04-05 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and method
|
MX2008016372A
(es)
*
|
2006-06-19 |
2009-05-28 |
Alpharma Inc |
Composiciones farmaceuticas.
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8504163B1
(en)
|
2006-06-30 |
2013-08-06 |
Boston Scientific Neuromodulation Corporation |
Cranially mounted stimulation systems and methods
|
US8401654B1
(en)
|
2006-06-30 |
2013-03-19 |
Boston Scientific Neuromodulation Corporation |
Methods and systems for treating one or more effects of deafferentation
|
US10208158B2
(en)
|
2006-07-10 |
2019-02-19 |
Medipacs, Inc. |
Super elastic epoxy hydrogel
|
US20080090897A1
(en)
|
2006-08-11 |
2008-04-17 |
The Johns Hopkins University |
Compositions and methods for neuroprotectin
|
US20080131398A1
(en)
*
|
2006-08-21 |
2008-06-05 |
United Therapeutics Corporation |
Combination therapy for treatment of viral infections
|
CN101610676B
(zh)
|
2006-09-22 |
2013-03-27 |
药品循环公司 |
布鲁顿酪氨酸激酶的抑制剂
|
US7445528B1
(en)
|
2006-09-29 |
2008-11-04 |
Boston Scientific Neuromodulation Corporation |
Connector assemblies
|
US8135548B2
(en)
|
2006-10-26 |
2012-03-13 |
Abbott Diabetes Care Inc. |
Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
|
US7347746B1
(en)
|
2006-10-27 |
2008-03-25 |
Boston Scientific Neuromodulation Corporation |
Receptacle connector assembly
|
DE102006051625A1
(de)
*
|
2006-11-02 |
2008-05-08 |
Bayer Materialscience Ag |
Kombinationstherapie substituierter Oxazolidinone
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
EP2091482A2
(de)
|
2006-12-01 |
2009-08-26 |
Allergan, Inc. |
Verfahren zur bestimmung optimaler intraokularer standorte für systeme zur verabreichung von medikamenten
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
US8846073B2
(en)
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
CA2674039A1
(en)
*
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
Sustained release formulation for tacrolimus
|
US20080176955A1
(en)
*
|
2007-01-16 |
2008-07-24 |
Victory Pharma, Inc. |
Combined administration of benzonatate and guaifenesin
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US20080199894A1
(en)
|
2007-02-15 |
2008-08-21 |
Abbott Diabetes Care, Inc. |
Device and method for automatic data acquisition and/or detection
|
US8121857B2
(en)
|
2007-02-15 |
2012-02-21 |
Abbott Diabetes Care Inc. |
Device and method for automatic data acquisition and/or detection
|
US8930203B2
(en)
|
2007-02-18 |
2015-01-06 |
Abbott Diabetes Care Inc. |
Multi-function analyte test device and methods therefor
|
US8732188B2
(en)
|
2007-02-18 |
2014-05-20 |
Abbott Diabetes Care Inc. |
Method and system for providing contextual based medication dosage determination
|
US8123686B2
(en)
|
2007-03-01 |
2012-02-28 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing rolling data in communication systems
|
WO2008113056A2
(en)
|
2007-03-14 |
2008-09-18 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
EP2146627B1
(de)
|
2007-04-14 |
2020-07-29 |
Abbott Diabetes Care Inc. |
Verfahren und vorrichtung zur bereitstellung von datenverarbeitung und -kontrolle in einem medizinischen kommunikationssystemen
|
ES2784736T3
(es)
|
2007-04-14 |
2020-09-30 |
Abbott Diabetes Care Inc |
Procedimiento y aparato para proporcionar el procesamiento y control de datos en un sistema de comunicación médica
|
EP2146625B1
(de)
|
2007-04-14 |
2019-08-14 |
Abbott Diabetes Care Inc. |
Verfahren und gerät zur bereitstellung von datenverarbeitung und kontrolle in einem medizinischen kommunikationssystem
|
US9204827B2
(en)
|
2007-04-14 |
2015-12-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in medical communication system
|
CA2683721C
(en)
|
2007-04-14 |
2017-05-23 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
|
EP2137637A4
(de)
|
2007-04-14 |
2012-06-20 |
Abbott Diabetes Care Inc |
Verfahren und vorrichtung zur datenverarbeitung und steuerung in einem medizinischen kommunikationssystem
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
US8456301B2
(en)
|
2007-05-08 |
2013-06-04 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8461985B2
(en)
|
2007-05-08 |
2013-06-11 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US7928850B2
(en)
|
2007-05-08 |
2011-04-19 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods
|
US8665091B2
(en)
|
2007-05-08 |
2014-03-04 |
Abbott Diabetes Care Inc. |
Method and device for determining elapsed sensor life
|
US8444560B2
(en)
|
2007-05-14 |
2013-05-21 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8560038B2
(en)
|
2007-05-14 |
2013-10-15 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8600681B2
(en)
|
2007-05-14 |
2013-12-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8103471B2
(en)
|
2007-05-14 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US9125548B2
(en)
|
2007-05-14 |
2015-09-08 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8239166B2
(en)
|
2007-05-14 |
2012-08-07 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US10002233B2
(en)
|
2007-05-14 |
2018-06-19 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US7996158B2
(en)
|
2007-05-14 |
2011-08-09 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8260558B2
(en)
|
2007-05-14 |
2012-09-04 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US20200037875A1
(en)
|
2007-05-18 |
2020-02-06 |
Dexcom, Inc. |
Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
|
EP2152350A4
(de)
|
2007-06-08 |
2013-03-27 |
Dexcom Inc |
Integrierte medikamentenfreisetzungsvorrichtung mit kontinuierlichem analytsensor
|
JP5680960B2
(ja)
|
2007-06-21 |
2015-03-04 |
アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. |
健康管理装置および方法
|
CN103251414B
(zh)
|
2007-06-21 |
2017-05-24 |
雅培糖尿病护理公司 |
用于分析物水平的检测的设备
|
US8160900B2
(en)
|
2007-06-29 |
2012-04-17 |
Abbott Diabetes Care Inc. |
Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
|
US7768386B2
(en)
|
2007-07-31 |
2010-08-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing data processing and control in a medical communication system
|
US8834366B2
(en)
|
2007-07-31 |
2014-09-16 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte sensor calibration
|
US8748648B2
(en)
*
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
US8263641B2
(en)
|
2007-09-10 |
2012-09-11 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US20090088681A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Mcintyre Jon T |
Device and method for the treatment of intra-abdominal disease
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
EP4098177A1
(de)
|
2007-10-09 |
2022-12-07 |
DexCom, Inc. |
Integriertes insulin-abgabesystem mit kontinuierlichem glucosesensor
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
US8409093B2
(en)
|
2007-10-23 |
2013-04-02 |
Abbott Diabetes Care Inc. |
Assessing measures of glycemic variability
|
US8216138B1
(en)
|
2007-10-23 |
2012-07-10 |
Abbott Diabetes Care Inc. |
Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
|
US8377031B2
(en)
*
|
2007-10-23 |
2013-02-19 |
Abbott Diabetes Care Inc. |
Closed loop control system with safety parameters and methods
|
EP2227635A2
(de)
*
|
2007-12-03 |
2010-09-15 |
Medipacs, Inc. |
Fluiddosiervorrichtung
|
WO2009088414A2
(en)
|
2007-12-06 |
2009-07-16 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20090164239A1
(en)
|
2007-12-19 |
2009-06-25 |
Abbott Diabetes Care, Inc. |
Dynamic Display Of Glucose Information
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
EP2242485A4
(de)
*
|
2008-02-15 |
2013-05-08 |
Sun Pharma Advanced Res Co Ltd |
Tablette mit gesteuerter freisetzung
|
WO2009126942A2
(en)
|
2008-04-10 |
2009-10-15 |
Abbott Diabetes Care Inc. |
Method and system for sterilizing an analyte sensor
|
US8591410B2
(en)
|
2008-05-30 |
2013-11-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
US7826382B2
(en)
|
2008-05-30 |
2010-11-02 |
Abbott Diabetes Care Inc. |
Close proximity communication device and methods
|
US8924159B2
(en)
|
2008-05-30 |
2014-12-30 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing glycemic control
|
WO2010009172A1
(en)
|
2008-07-14 |
2010-01-21 |
Abbott Diabetes Care Inc. |
Closed loop control system interface and methods
|
EP2334185A4
(de)
|
2008-08-19 |
2011-09-21 |
Knopp Neurosciences Inc |
Zusammensetzungen und verfahren zur verwendung von (r)-pramipexol
|
RU2472791C2
(ru)
|
2008-08-27 |
2013-01-20 |
КалсиМедика Инк. |
Соединения, модулирующие внутриклеточный кальций
|
US8734422B2
(en)
|
2008-08-31 |
2014-05-27 |
Abbott Diabetes Care Inc. |
Closed loop control with improved alarm functions
|
US8622988B2
(en)
|
2008-08-31 |
2014-01-07 |
Abbott Diabetes Care Inc. |
Variable rate closed loop control and methods
|
US9943644B2
(en)
|
2008-08-31 |
2018-04-17 |
Abbott Diabetes Care Inc. |
Closed loop control with reference measurement and methods thereof
|
US20100057040A1
(en)
|
2008-08-31 |
2010-03-04 |
Abbott Diabetes Care, Inc. |
Robust Closed Loop Control And Methods
|
US8986208B2
(en)
|
2008-09-30 |
2015-03-24 |
Abbott Diabetes Care Inc. |
Analyte sensor sensitivity attenuation mitigation
|
WO2010039801A2
(en)
|
2008-10-02 |
2010-04-08 |
The J. David Gladstone Institutes |
Methods of treating hepatitis c virus infection
|
US20100104654A1
(en)
*
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US9326707B2
(en)
|
2008-11-10 |
2016-05-03 |
Abbott Diabetes Care Inc. |
Alarm characterization for analyte monitoring devices and systems
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
DE102008059206A1
(de)
|
2008-11-27 |
2010-06-10 |
Bayer Schering Pharma Aktiengesellschaft |
Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
|
US8103456B2
(en)
|
2009-01-29 |
2012-01-24 |
Abbott Diabetes Care Inc. |
Method and device for early signal attenuation detection using blood glucose measurements
|
WO2010088548A1
(en)
|
2009-01-29 |
2010-08-05 |
Forsight Labs, Llc |
Posterior segment drug delivery
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US20100198034A1
(en)
|
2009-02-03 |
2010-08-05 |
Abbott Diabetes Care Inc. |
Compact On-Body Physiological Monitoring Devices and Methods Thereof
|
US20100204325A1
(en)
|
2009-02-11 |
2010-08-12 |
Allergan, Inc. |
Valproic acid drug delivery systems and intraocular therapeutic uses thereof
|
EP2408449A4
(de)
|
2009-03-18 |
2012-08-08 |
Univ Leland Stanford Junior |
Verfahren und zusammensetzungen zur behandlung von flaviviridae-virusinfektionen
|
WO2010121084A1
(en)
|
2009-04-15 |
2010-10-21 |
Abbott Diabetes Care Inc. |
Analyte monitoring system having an alert
|
DK2421901T3
(en)
|
2009-04-24 |
2016-01-11 |
Tissue Tech Inc |
Compositions comprising HC-HA complex, and methods of use thereof
|
US9226701B2
(en)
|
2009-04-28 |
2016-01-05 |
Abbott Diabetes Care Inc. |
Error detection in critical repeating data in a wireless sensor system
|
WO2010127187A1
(en)
|
2009-04-29 |
2010-11-04 |
Abbott Diabetes Care Inc. |
Method and system for providing data communication in continuous glucose monitoring and management system
|
EP2425209A4
(de)
|
2009-04-29 |
2013-01-09 |
Abbott Diabetes Care Inc |
Verfahren und system für die echtzeit-kalibrierung eines analytsensors mit rückwirkender füllung
|
US20100278897A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Intraocular bioactive agent delivery system with molecular partitioning system
|
US8632511B2
(en)
*
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
WO2010138856A1
(en)
|
2009-05-29 |
2010-12-02 |
Abbott Diabetes Care Inc. |
Medical device antenna systems having external antenna configurations
|
US8956654B2
(en)
|
2009-06-02 |
2015-02-17 |
Dow Global Technologies Llc |
Sustained release dosage form
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
RU2012101792A
(ru)
*
|
2009-06-19 |
2013-07-27 |
Нопп Ньюросайенсиз, Инк. |
Композиции и способы для лечения бокового амиотрофического склероза
|
US8613892B2
(en)
|
2009-06-30 |
2013-12-24 |
Abbott Diabetes Care Inc. |
Analyte meter with a moveable head and methods of using the same
|
ES2776474T3
(es)
|
2009-07-23 |
2020-07-30 |
Abbott Diabetes Care Inc |
Sistema de medición continua de analitos
|
WO2011014851A1
(en)
|
2009-07-31 |
2011-02-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing analyte monitoring system calibration accuracy
|
JP5641483B2
(ja)
*
|
2009-08-18 |
2014-12-17 |
国立大学法人東北大学 |
持続性ドラッグデリバリーシステム
|
WO2011026148A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte monitoring system and methods for managing power and noise
|
CA2765712A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Medical devices and methods
|
WO2011026147A1
(en)
|
2009-08-31 |
2011-03-03 |
Abbott Diabetes Care Inc. |
Analyte signal processing device and methods
|
EP3988470B1
(de)
|
2009-08-31 |
2023-06-28 |
Abbott Diabetes Care Inc. |
Anzeigeeinheiten für ein medizinisches gerät
|
WO2011032011A1
(en)
|
2009-09-10 |
2011-03-17 |
Medipacs, Inc. |
Low profile actuator and improved method of caregiver controlled administration of therapeutics
|
DE102009042855A1
(de)
*
|
2009-09-24 |
2011-03-31 |
Pfenning Elektroanlagen Gmbh |
Portalhubwagen zum Einsatz in Containerterminals und für allgemeine Transportaufgaben
|
US9320461B2
(en)
|
2009-09-29 |
2016-04-26 |
Abbott Diabetes Care Inc. |
Method and apparatus for providing notification function in analyte monitoring systems
|
WO2011041531A1
(en)
|
2009-09-30 |
2011-04-07 |
Abbott Diabetes Care Inc. |
Interconnect for on-body analyte monitoring device
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
US8185181B2
(en)
|
2009-10-30 |
2012-05-22 |
Abbott Diabetes Care Inc. |
Method and apparatus for detecting false hypoglycemic conditions
|
PL2498783T3
(pl)
|
2009-11-09 |
2019-04-30 |
Allergan Inc |
Kompozycje i sposoby stymulowania wzrostu włosów
|
WO2011075481A1
(en)
|
2009-12-16 |
2011-06-23 |
Allergan, Inc. |
Intracameral devices for sustained delivery
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
CA2785468A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
US20110172639A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Device and method for delivery of microneedle to desired depth within the skin
|
US20110172645A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Wearable drug delivery device including integrated pumping and activation elements
|
US20110172609A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
US20110172637A1
(en)
*
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Drug delivery device including tissue support structure
|
USD924406S1
(en)
|
2010-02-01 |
2021-07-06 |
Abbott Diabetes Care Inc. |
Analyte sensor inserter
|
US9500186B2
(en)
|
2010-02-01 |
2016-11-22 |
Medipacs, Inc. |
High surface area polymer actuator with gas mitigating components
|
WO2011112753A1
(en)
|
2010-03-10 |
2011-09-15 |
Abbott Diabetes Care Inc. |
Systems, devices and methods for managing glucose levels
|
CA3135001A1
(en)
|
2010-03-24 |
2011-09-29 |
Abbott Diabetes Care Inc. |
Medical device inserters and processes of inserting and using medical devices
|
TR201802207T4
(tr)
|
2010-03-29 |
2018-03-21 |
Astellas Pharma Inc |
Kontrollü Salımlı Farmasötik Bileşim.
|
ES2602475T3
(es)
|
2010-04-15 |
2017-02-21 |
Tracon Pharmaceuticals, Inc. |
Potenciación de la actividad anticáncer por terapia de combinación con inhibidores de la vía BER
|
AU2011248579A1
(en)
|
2010-04-27 |
2012-11-29 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
EP2563776B1
(de)
|
2010-04-27 |
2016-06-08 |
Calcimedica, Inc. |
Verbindungen als modulatoren von intrazellulärem calcium
|
NZ702485A
(en)
|
2010-06-03 |
2016-04-29 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|
US8635046B2
(en)
|
2010-06-23 |
2014-01-21 |
Abbott Diabetes Care Inc. |
Method and system for evaluating analyte sensor response characteristics
|
US10092229B2
(en)
|
2010-06-29 |
2018-10-09 |
Abbott Diabetes Care Inc. |
Calibration of analyte measurement system
|
US11064921B2
(en)
|
2010-06-29 |
2021-07-20 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
RS61601B1
(sr)
|
2010-08-05 |
2021-04-29 |
Forsight Vision4 Inc |
Aparati za ubrizgavanje za dostavu leka
|
US9492315B2
(en)
|
2010-08-05 |
2016-11-15 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
US10617557B2
(en)
|
2010-08-05 |
2020-04-14 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
AU2011293201B2
(en)
|
2010-08-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
WO2012048168A2
(en)
|
2010-10-07 |
2012-04-12 |
Abbott Diabetes Care Inc. |
Analyte monitoring devices and methods
|
WO2012061556A1
(en)
|
2010-11-03 |
2012-05-10 |
Flugen, Inc. |
Wearable drug delivery device having spring drive and sliding actuation mechanism
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
US8518440B2
(en)
|
2010-12-21 |
2013-08-27 |
Confluent Surgical, Inc. |
Biodegradable osmotic pump implant for drug delivery
|
PT2665477E
(pt)
|
2011-01-20 |
2016-01-12 |
Bionevia Pharmaceuticals Inc |
Composições de libertação modificada de epalrestat ou de um seu derivado e métodos para a sua utilização
|
US8801768B2
(en)
*
|
2011-01-21 |
2014-08-12 |
Endologix, Inc. |
Graft systems having semi-permeable filling structures and methods for their use
|
CA3177983A1
(en)
|
2011-02-28 |
2012-11-15 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
US10136845B2
(en)
|
2011-02-28 |
2018-11-27 |
Abbott Diabetes Care Inc. |
Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
|
DE102011007272A1
(de)
|
2011-04-13 |
2012-10-18 |
Bayer Pharma Aktiengesellschaft |
Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
|
WO2012142502A2
(en)
|
2011-04-15 |
2012-10-18 |
Dexcom Inc. |
Advanced analyte sensor calibration and error detection
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
CA2837878A1
(en)
|
2011-06-10 |
2012-12-13 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
CN103917093B
(zh)
|
2011-06-14 |
2017-08-11 |
比卡姆药品公司 |
视蛋白结合配体、组合物及使用方法
|
WO2012175698A1
(en)
|
2011-06-23 |
2012-12-27 |
Université Libre de Bruxelles |
Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
|
EP2726016B1
(de)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
US20130017259A1
(en)
*
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
EP2739252A4
(de)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
Abgabe kleiner moleküle über eine implantierbare therapeutische vorrichtung
|
JP2014527801A
(ja)
|
2011-09-01 |
2014-10-23 |
ユニバーシティ オブ サザン カリフォルニア |
ハイスループットペプチドミメティックを調製するための方法、経口バイオアベイラブルな薬物およびそれを含有する組成物
|
EP2755648B1
(de)
|
2011-09-13 |
2017-03-08 |
Pharmacyclics LLC |
Formulierungen des histondeacetylase-inhibitors in kombination mit bendamustin und verwendungen davon
|
RS61758B1
(sr)
|
2011-09-16 |
2021-05-31 |
Forsight Vision4 Inc |
Aparati za razmenu tečnosti
|
EP2768307B1
(de)
|
2011-10-19 |
2020-03-18 |
Bikam Pharmaceuticals, Inc. |
Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür
|
WO2013066873A1
(en)
|
2011-10-31 |
2013-05-10 |
Abbott Diabetes Care Inc. |
Electronic devices having integrated reset systems and methods thereof
|
US9622691B2
(en)
|
2011-10-31 |
2017-04-18 |
Abbott Diabetes Care Inc. |
Model based variable risk false glucose threshold alarm prevention mechanism
|
JP6443802B2
(ja)
|
2011-11-07 |
2018-12-26 |
アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. |
分析物モニタリング装置および方法
|
WO2013078422A2
(en)
|
2011-11-23 |
2013-05-30 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US8710993B2
(en)
|
2011-11-23 |
2014-04-29 |
Abbott Diabetes Care Inc. |
Mitigating single point failure of devices in an analyte monitoring system and methods thereof
|
US9317656B2
(en)
|
2011-11-23 |
2016-04-19 |
Abbott Diabetes Care Inc. |
Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CA2862807A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
CA2862746A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
BR112014013649A2
(pt)
|
2011-12-06 |
2020-10-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
métodos e agentes para o tratamento de doenças virais e usos dos referidos agentes
|
EP4344633A2
(de)
|
2011-12-11 |
2024-04-03 |
Abbott Diabetes Care, Inc. |
Analytsensorvorrichtungen, verbindungen und verfahren
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
SI2800565T1
(sl)
|
2012-01-06 |
2020-10-30 |
Lundbeck La Jolla Research Center, Inc. |
Karbamatne spojine in metode izdelave in uporabe le-teh
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
CA2864300A1
(en)
|
2012-02-16 |
2013-08-22 |
Atyr Pharma, Inc. |
Histidyl-trna synthetases for treating autoimmune and inflammatory diseases
|
CN104302689A
(zh)
|
2012-03-14 |
2015-01-21 |
麦德医像公司 |
含有过量活性分子的智能聚合物材料
|
WO2013167453A1
(en)
|
2012-05-07 |
2013-11-14 |
Bayer Pharma Aktiengesellschaft |
Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
|
CA2991994C
(en)
|
2012-06-04 |
2022-06-28 |
Pharmacyclics Llc |
Pharmaceutical formulation for oral administration comprising ibrutinib
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
UY34856A
(es)
|
2012-07-03 |
2013-12-31 |
Bayer Pharma AG |
Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
|
US10040821B2
(en)
|
2012-07-11 |
2018-08-07 |
Tissuetech, Inc. |
Compositions containing HC-HA/PTX3 complexes and methods of use thereof
|
EP2890297B1
(de)
|
2012-08-30 |
2018-04-11 |
Abbott Diabetes Care, Inc. |
Ausfallerkennung bei kontinuierlichen analytüberwachungsdaten bei datenabweichungen
|
US9968306B2
(en)
|
2012-09-17 |
2018-05-15 |
Abbott Diabetes Care Inc. |
Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
|
WO2014052136A1
(en)
|
2012-09-26 |
2014-04-03 |
Abbott Diabetes Care Inc. |
Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
|
WO2014052914A1
(en)
|
2012-09-28 |
2014-04-03 |
University Of Washington Through Its Center For Commercialization |
Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
|
US9717741B2
(en)
|
2012-10-11 |
2017-08-01 |
Anaplasi Pharmaceuticals Llc |
Method and compositions for treating psoriasis
|
ES2793404T3
(es)
|
2012-10-11 |
2020-11-13 |
Anaplasi Pharmaceuticals Llc |
Método y composiciones para el tratamiento de la psoriasis
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
GB2510826B
(en)
|
2013-02-13 |
2015-09-02 |
Animax Ltd |
Improvements in or relating to release of a beneficial substance from a bolus
|
US20140234389A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
EP2968113B8
(de)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systeme zur verzögerten intraokularen abgabe schwerlöslicher verbindungen aus einem implantat mit einem portabgabesystem
|
US10433773B1
(en)
|
2013-03-15 |
2019-10-08 |
Abbott Diabetes Care Inc. |
Noise rejection methods and apparatus for sparsely sampled analyte sensor data
|
EP2983468A4
(de)
|
2013-03-15 |
2016-09-07 |
Durect Corp |
Zusammensetzungen mit rheologiemodifikator zur reduzierung der auflösungsvariabilität
|
US9474475B1
(en)
|
2013-03-15 |
2016-10-25 |
Abbott Diabetes Care Inc. |
Multi-rate analyte sensor data collection with sample rate configurable signal processing
|
US10076285B2
(en)
|
2013-03-15 |
2018-09-18 |
Abbott Diabetes Care Inc. |
Sensor fault detection using analyte sensor data pattern comparison
|
CA2907681C
(en)
|
2013-03-28 |
2022-11-22 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
PT3019167T
(pt)
|
2013-07-12 |
2021-03-04 |
Knopp Biosciences Llc |
Tratamento de níveis elevados de eosinófilos e/ou basófilos
|
CA2921378A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
EP3033081B1
(de)
|
2013-08-13 |
2021-05-12 |
Knopp Biosciences LLC |
Zusammensetzungen und verfahren zur behandlung von chronischer nesselsucht
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
JP6345786B2
(ja)
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|
US11229382B2
(en)
|
2013-12-31 |
2022-01-25 |
Abbott Diabetes Care Inc. |
Self-powered analyte sensor and devices using the same
|
US20170185748A1
(en)
|
2014-03-30 |
2017-06-29 |
Abbott Diabetes Care Inc. |
Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
|
EP3134418A4
(de)
|
2014-04-23 |
2018-01-03 |
The Research Foundation for The State University of New York |
Schnelle und effiziente reaktion zur bioorthogonalen reaktion und borhaltige, zusammen damit nützliche heterocyclen
|
US10206932B2
(en)
|
2014-05-22 |
2019-02-19 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
RU2695563C2
(ru)
|
2014-07-15 |
2019-07-24 |
Форсайт Вижн4, Инк. |
Способ и устройство для доставки глазного имплантата
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
WO2016016770A1
(en)
|
2014-07-26 |
2016-02-04 |
Wockhardt Limited |
A novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof
|
WO2016022750A1
(en)
|
2014-08-08 |
2016-02-11 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
JP7037360B2
(ja)
|
2014-11-10 |
2022-03-16 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
拡張可能な薬物送達デバイス
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10213586B2
(en)
|
2015-01-28 |
2019-02-26 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
DK3253766T3
(da)
|
2015-02-06 |
2019-12-09 |
Univ Washington |
Forbindelser og fremgangsmåder til forebyggelse eller behandling af sansehårscelledød
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
WO2016132233A1
(en)
|
2015-02-20 |
2016-08-25 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Controlled release oral dosage form of gaba receptor agonist with enhanced pharmacokinetics
|
US20160243288A1
(en)
|
2015-02-23 |
2016-08-25 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
WO2016138479A1
(en)
|
2015-02-27 |
2016-09-01 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
PT3265084T
(pt)
|
2015-03-03 |
2024-02-13 |
Pharmacyclics Llc |
Formulações farmacêuticas de inibidor de tirosina cinase de bruton
|
CA2977814A1
(en)
|
2015-03-12 |
2016-09-15 |
Chrono Therapeutics Inc. |
Craving input and support system
|
MA41828A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
|
MA41827A
(fr)
|
2015-03-27 |
2018-01-30 |
Pharmacyclics Llc |
Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
|
US10575976B2
(en)
|
2015-04-30 |
2020-03-03 |
Dynamic Mouth Devices, L.L.C. |
Method and apparatus for weight management utilizing an intra-oral device
|
BR112017024253A2
(pt)
|
2015-05-11 |
2018-07-24 |
Abide Therapeutics Inc |
métodos de tratamento de inflamação ou dor neuropática.
|
WO2016183493A1
(en)
|
2015-05-14 |
2016-11-17 |
Abbott Diabetes Care Inc. |
Compact medical device inserters and related systems and methods
|
US10213139B2
(en)
|
2015-05-14 |
2019-02-26 |
Abbott Diabetes Care Inc. |
Systems, devices, and methods for assembling an applicator and sensor control device
|
JP2018516869A
(ja)
|
2015-05-20 |
2018-06-28 |
ティッシュテック,インク. |
上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
|
EP3319518A4
(de)
|
2015-07-10 |
2019-03-13 |
Abbott Diabetes Care Inc. |
System, vorrichtung und verfahren zur dynamischen glukoseprofilreaktion auf physiologische parameter
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
AU2016303688B2
(en)
|
2015-07-31 |
2023-06-15 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
WO2017040617A1
(en)
|
2015-08-31 |
2017-03-09 |
Pharmacyclics Llc |
Btk inhibitor combinations for treating multiple myeloma
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
DK3827838T3
(da)
|
2015-12-16 |
2023-06-26 |
Walter & Eliza Hall Inst Medical Res |
Hæmning af cytokin-induceret sh2-protein i nk-celler
|
EA201891664A1
(ru)
|
2016-01-19 |
2019-02-28 |
Янссен Фармацевтика Нв |
Составы/композиции, содержащие ингибитор btk
|
CA3008338A1
(en)
|
2016-01-19 |
2017-07-27 |
Janssen Pharmaceutica Nv |
Formulations/compositions comprising a btk inhibitor
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
WO2017147146A1
(en)
|
2016-02-23 |
2017-08-31 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
CN109310700A
(zh)
|
2016-04-04 |
2019-02-05 |
希诺皮亚生物科学公司 |
使用曲匹地尔治疗锥体外系综合征
|
MX2018012021A
(es)
|
2016-04-05 |
2019-01-24 |
Forsight Vision4 Inc |
Dispositivos de administracion de farmacos oculares implantables.
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
CN109562281B
(zh)
|
2016-05-25 |
2021-12-17 |
同心镇痛药物公司 |
酚类trpv1激动剂的前药与局部麻醉药和血管收缩剂联合用于改善局部麻醉
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
PT3484862T
(pt)
|
2016-07-18 |
2021-11-17 |
Arthrosi Therapeutics Inc |
Compostos, composições e métodos para o tratamento ou a prevenção de um sintoma associado a gota ou hiperuricemia
|
CN115215807A
(zh)
|
2016-08-26 |
2022-10-21 |
科泰纳制药公司 |
Olig2活性的抑制
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
LT3541807T
(lt)
|
2016-11-16 |
2021-12-27 |
H. Lundbeck A/S |
Magl inhibitoriaus kristalinė forma
|
WO2018093950A1
(en)
|
2016-11-16 |
2018-05-24 |
Abide Therapeutics, Inc. |
Pharmaceutical formulations
|
EP3565589A1
(de)
|
2017-01-04 |
2019-11-13 |
Research Institute at Nationwide Children's Hospital |
Dnabii-impfstoffe und antikörper mit erhöhter aktivität
|
AU2018206560A1
(en)
|
2017-01-04 |
2019-07-18 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
CN115444410A
(zh)
|
2017-01-23 |
2022-12-09 |
雅培糖尿病护理公司 |
用于插入体内分析物传感器的施加器及组件
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
US11596330B2
(en)
|
2017-03-21 |
2023-03-07 |
Abbott Diabetes Care Inc. |
Methods, devices and system for providing diabetic condition diagnosis and therapy
|
WO2018200885A1
(en)
|
2017-04-26 |
2018-11-01 |
Neurocentria, Inc. |
Magnesium compositions and methods of use
|
EP3675865A4
(de)
|
2017-09-01 |
2021-06-02 |
University of Washington |
Kristalline formen von verbindungen zur vorbeugung oder behandlung von sensorischem haarzelltod
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US11331022B2
(en)
|
2017-10-24 |
2022-05-17 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
US11382540B2
(en)
|
2017-10-24 |
2022-07-12 |
Dexcom, Inc. |
Pre-connected analyte sensors
|
BR112020010053A2
(pt)
|
2017-11-21 |
2020-11-03 |
Forsight Vision4, Inc. |
aparelho para troca de fluido para sistema de liberação de porta expansível e métodos de uso do mesmo
|
EP3752133A1
(de)
|
2018-02-16 |
2020-12-23 |
Esperion Therapeutics, Inc. |
Retard-formulierungen von bempedoinsäure
|
WO2019165993A1
(zh)
|
2018-02-28 |
2019-09-06 |
上海汉都医药科技有限公司 |
一种药物组合物及其制备方法和应用
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
WO2019173384A1
(en)
|
2018-03-05 |
2019-09-12 |
Kashiv Pharma Llc |
Programmable pharmaceutical compositions for chrono drug release
|
US11911513B2
(en)
|
2018-05-23 |
2024-02-27 |
Shanghai Wd Pharmaceutical Co., Ltd |
Controlled-release system of active pharmaceutical ingredient and preparation method therefor
|
CN112118886B
(zh)
|
2018-05-23 |
2022-08-23 |
上海汉都医药科技有限公司 |
活性药物成分的控释系统及其制备方法
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
SG11202100369WA
(en)
|
2018-07-24 |
2021-02-25 |
Bayer Ag |
Pharmaceutical dosage form which can be administered orally and has modified release
|
EP3826619A1
(de)
|
2018-07-24 |
2021-06-02 |
Bayer Aktiengesellschaft |
Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
|
US10905667B2
(en)
|
2018-07-24 |
2021-02-02 |
Bayer Pharma Aktiengesellschaft |
Orally administrable modified-release pharmaceutical dosage form
|
AU2019310118A1
(en)
|
2018-07-27 |
2021-03-11 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic TRPV1 agonists
|
EP3906026A4
(de)
|
2018-12-31 |
2022-10-19 |
Biomea Fusion, LLC |
Irreversible inhibitoren der menin-mll-interaktion
|
CA3133093A1
(en)
|
2019-03-15 |
2020-09-24 |
Unicycive Therapeutics, Inc. |
Nicorandil derivatives
|
USD1002852S1
(en)
|
2019-06-06 |
2023-10-24 |
Abbott Diabetes Care Inc. |
Analyte sensor device
|
EP3750528A1
(de)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Zusammensetzungen zur behandlung von dystrophien und myotonie
|
AU2020311897A1
(en)
|
2019-07-08 |
2022-02-03 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
JP2023523219A
(ja)
|
2020-04-21 |
2023-06-02 |
ハー・ルンドベック・アクチエゼルスカベット |
モノアシルグリセロールリパーゼ阻害剤の合成
|
LT4153136T
(lt)
|
2020-06-10 |
2024-03-25 |
Auspex Pharmaceuticals, Inc. |
Osmosinės vaisto formos, apimančios deutetrabenaziną ir jo vartojimo būdai
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
USD999913S1
(en)
|
2020-12-21 |
2023-09-26 |
Abbott Diabetes Care Inc |
Analyte sensor inserter
|
CA3204457A1
(en)
|
2021-01-06 |
2022-07-14 |
Ben SESSA |
Mdma in the treatment of alcohol use disorder
|
WO2022238507A1
(en)
|
2021-05-11 |
2022-11-17 |
Awakn Ls Europe Holdings Limited |
Therapeutic aminoindane compounds and compositions
|
CN115400092A
(zh)
*
|
2021-05-28 |
2022-11-29 |
上海博志研新药物技术有限公司 |
硝苯地平美托洛尔缓释组合物、其制备方法及应用
|
WO2022256720A2
(en)
|
2021-06-03 |
2022-12-08 |
Arcadia Medicine, Inc. |
Enantiomeric entactogen compositions and methods of their use
|
WO2023018825A1
(en)
|
2021-08-11 |
2023-02-16 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
AU2022331496A1
(en)
|
2021-08-20 |
2024-02-29 |
Biomea Fusion, Inc. |
Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cancer
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
US11945785B2
(en)
|
2021-12-30 |
2024-04-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of FLT3
|
WO2023139163A1
(en)
|
2022-01-19 |
2023-07-27 |
Awakn Ls Europe Holdings Limited |
1,3-benzodioxole esters and their therapeutic use
|
CN115490316B
(zh)
*
|
2022-01-24 |
2023-09-12 |
成都理工大学 |
一种可再利用的地下水营养物质缓释胶囊体
|
WO2023156565A1
(en)
|
2022-02-16 |
2023-08-24 |
Awakn Ls Europe Holdings Limited |
Bridged ring compounds and their therapeutic use as cns agents
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
WO2023240186A1
(en)
|
2022-06-08 |
2023-12-14 |
Auspex Pharmaceuticals, Inc. |
Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
|
WO2024011142A1
(en)
|
2022-07-06 |
2024-01-11 |
Oppilan Pharma Limited |
Crystalline forms of an s1p receptor modulator
|
US11931224B1
(en)
*
|
2022-12-19 |
2024-03-19 |
Robert Parker |
Tooth pod
|